Should Deep Brain Stimulation Programs Be Halted During the COVID-19 Pandemic? Balancing the Risk of COVID-19 Infection Against the Survival Benefits of DBS.

Bara, Gregor A; Maciaczyk, Jaroslaw

Bara, Gregor A; Maciaczyk, Jaroslaw.

Bara GA; Stereotactic and Functional Neurosurgery, Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.
Maciaczyk J; Stereotactic and Functional Neurosurgery, Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.

Neuromodulation ; 23(8): 1222-1223, 2020 12.

Article in English | MEDLINE | ID: covidwho-919204

Subject(s)

COVID-19/epidemiology; Deep Brain Stimulation/standards; Pandemics; Parkinson Disease/therapy; Disease Management; Humans; Pandemics/prevention & control; Parkinson Disease/mortality; Risk Factors; Survival Rate/trends

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Deep Brain Stimulation / Pandemics / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Neuromodulation Year: 2020 Document Type: Article Affiliation country: Ner.13309

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google